Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HLSNYSEARCA:IDXNYSE:MVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHLSHLS TherapeuticsC$4.68+0.6%C$4.42C$3.00▼C$4.98C$104.12M1.0713,643 shs2,821 shsIDXVanEck Indonesia Index ETF$14.91+1.7%$12.97$10.93▼$19.10$32.80M0.5351,786 shs10,039 shsMVFBlackRock MuniVest Fund$6.68-0.2%$6.85$6.50▼$7.64$402.66M0.59102,482 shs73,642 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHLSHLS Therapeutics+0.65%-2.50%+11.16%+12.23%+21.56%IDXVanEck Indonesia Index ETF+1.71%+3.83%+15.22%+7.65%-10.56%MVFBlackRock MuniVest Fund+0.09%-1.75%-0.51%-8.30%-5.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHLSHLS Therapeutics0.4989 of 5 stars1.00.01.70.02.31.70.0IDXVanEck Indonesia Index ETFN/AN/AN/AN/AN/AN/AN/AN/AMVFBlackRock MuniVest FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHLSHLS Therapeutics 2.00HoldC$4.50-3.85% DownsideIDXVanEck Indonesia Index ETF 0.00N/AN/AN/AMVFBlackRock MuniVest Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IDX, HLS, ACL, and MVF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/26/2025HLSHLS TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHoldC$3.50 ➝ C$4.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHLSHLS TherapeuticsC$40.13M2.59C$0.31 per share15.22C$2.51 per share1.86IDXVanEck Indonesia Index ETFN/AN/AN/AN/AN/AN/AMVFBlackRock MuniVest Fund$11.04M36.49N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHLSHLS Therapeutics-C$15.53M-C$1.00N/A∞N/A-38.70%-25.27%-2.89%N/AIDXVanEck Indonesia Index ETFN/AN/A11.13∞N/AN/AN/AN/AN/AMVFBlackRock MuniVest FundN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHLSHLS TherapeuticsC$0.204.27%N/AN/A N/AIDXVanEck Indonesia Index ETF$0.593.96%N/AN/AN/AMVFBlackRock MuniVest Fund$0.355.24%-1.52%N/AN/ALatest IDX, HLS, ACL, and MVF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025MVFBlackRock MuniVest Fundmonthly$0.03606.3%5/15/20255/15/20256/2/20254/3/2025MVFBlackRock MuniVest Fundmonthly$0.03606.1%4/15/20254/15/20255/1/20253/3/2025MVFBlackRock MuniVest FundMonthly$0.03605.94%3/14/20253/14/20254/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHLSHLS Therapeutics86.501.561.01IDXVanEck Indonesia Index ETFN/AN/AN/AMVFBlackRock MuniVest FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHLSHLS Therapeutics65.20%IDXVanEck Indonesia Index ETFN/AMVFBlackRock MuniVest Fund48.16%Insider OwnershipCompanyInsider OwnershipHLSHLS Therapeutics0.37%IDXVanEck Indonesia Index ETFN/AMVFBlackRock MuniVest Fund1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHLSHLS Therapeutics9122.25 millionN/ANot OptionableIDXVanEck Indonesia Index ETFN/A2.20 millionN/ANot OptionableMVFBlackRock MuniVest Fund147,00060.31 million59.71 millionNot OptionableIDX, HLS, ACL, and MVF HeadlinesRecent News About These CompaniesLogan Stone Capital LLC Cuts Stake in BlackRock MuniVest Fund, Inc. (NYSE:MVF)May 14, 2025 | marketbeat.comBlackRock MuniVest Fund, Inc. (NYSE:MVF) Announces $0.04 Monthly DividendMay 7, 2025 | marketbeat.comAQR Arbitrage LLC Sells 96,500 Shares of BlackRock MuniVest Fund, Inc. (NYSE:MVF)May 4, 2025 | marketbeat.comInvesco Ltd. Buys 80,197 Shares of BlackRock MuniVest Fund, Inc. (NYSE:MVF)May 2, 2025 | marketbeat.comRaymond James Financial Inc. Buys Shares of 707,152 BlackRock MuniVest Fund, Inc. (NYSE:MVF)April 28, 2025 | marketbeat.com(MVF) Long Term Investment AnalysisJanuary 27, 2025 | news.stocktradersdaily.com(MVF) Investment ReportJanuary 16, 2025 | news.stocktradersdaily.com(MVF) Pivots Trading Plans and Risk ControlsJanuary 6, 2025 | news.stocktradersdaily.com(MVF) Trading AdviceDecember 5, 2024 | news.stocktradersdaily.com(MVF) Technical DataNovember 25, 2024 | news.stocktradersdaily.comHow To Trade (MVF)November 16, 2024 | news.stocktradersdaily.comBlackRock 40/60 Target Allocation KNovember 8, 2024 | morningstar.comJio Financial Services and BlackRock incorporate AMCs to undertake mutual funds businessOctober 31, 2024 | livemint.com(MVF) Investment Analysis and AdviceOctober 14, 2024 | news.stocktradersdaily.comBlackRock MuniVest Fund, Inc. (MVF)September 15, 2024 | finance.yahoo.comObjective long/short (MVF) ReportAugust 2, 2024 | news.stocktradersdaily.com(MVF) Proactive StrategiesJuly 25, 2024 | news.stocktradersdaily.comBlackRock MuniVest Fund, Inc. (MVF) Announces Adoption of Discount Management ProgramMay 3, 2024 | businesswire.comBlackRock MuniVest declares $0.03 dividendMarch 4, 2024 | msn.comBlackRock Advantage SMID Cap Fund;Investor AMarch 2, 2024 | wsj.comBlackRock High Equity Income Fund;Investor CFebruary 24, 2024 | wsj.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumNVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?OXY Stock Rebound Begins Following Solid Earnings BeatBy Thomas Hughes | May 9, 2025View OXY Stock Rebound Begins Following Solid Earnings BeatIDX, HLS, ACL, and MVF Company DescriptionsHLS Therapeutics TSE:HLSC$4.68 +0.03 (+0.65%) As of 05/23/2025 02:30 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.VanEck Indonesia Index ETF NYSEARCA:IDX$14.91 +0.25 (+1.71%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$14.58 -0.32 (-2.18%) As of 05/23/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Market Vectors Indonesia Index ETF (IDX) seeks, before fees and expenses, the price and yield performance of the Market Vectors Indonesia Index (the Index). The Index provides exposure to publicly traded companies that are domiciled and primarily listed in Indonesia, or that generate at least 50% of their revenues in Indonesia. The Index is the property of Market Vectors Index Solutions GmbH, which has contracted with Structured Solutions AG to maintain and calculate the Index.BlackRock MuniVest Fund NYSE:MVF$6.68 -0.01 (-0.21%) Closing price 05/23/2025 03:58 PM EasternExtended Trading$6.68 0.00 (-0.01%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BlackRock MuniVest Fund, Inc. is a closed-ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in investment grade, long term municipal obligations that are exempt from federal income taxes. The fund seeks to invest in securities with maturities of more than ten years. BlackRock MuniVest Fund, Inc. was formed on September 29, 1988 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
